Transkriptioner

Good morning all, and welcome to this presentation of our results for the first quarter here at Fasadgruppen. In the room, we have our CEO, Martin Jacobsson, and our CFO, Casper Tamm and myself, Magnu…

Hi, everyone, and welcome to this earnings call for Surgical Science for the first quarter of 2026. My name is Tom Englund. I'm the CEO. And with me today I have Anna Berry, our CFO. We'll start wit…

Welcome to Addtech's 2025/2026 Year-End Report presentation. For the first part of the presentation, participants will be in listen-only mode. During the Questions and Answers session, participants ar…

Good morning and welcome to my presentation for the first quarter of 2026. It has been a strong start of the year for BioArctic following a transformative year of 2025 with record financial results. I…

Thank you. Good afternoon, everyone, and thank you for joining us. I am Hilde Steineger, CEO of Cantargia. Today I will present our Q1 2026 update and progress across all our IL1RAP platform, includin…

Thank you very much. Good morning to you out there. Good morning everyone. And we're going to start like we usually do. You know, me going through some slides and then Hans following up. And we hope…

Good morning, everyone. Welcome to Lagercrantz Group Year-end Report. Call. We, as you know, have our financial year-end at the end of March every year. So we have just concluded our numbers and relea…

Välkommen till HomeMaid-gruppens investerarpresentation. För det första kvartalet 2026. Mitt namn är Stefan Högkvist. Jag arbetar som VD för HomeMaid-gruppen. Med mig har jag Michaela Maier, bolagets…

Hej och välkomna! Vi ska idag presentera Nordrest senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bolaget och med mig i…

Thank you very much. And hello and welcome to Cinclus Pharma first quarter 2026 earnings call. As you already know, I'm Christer Ahlberg, CEO of Cinclus Pharma. And with me here today, I also have our…

Good morning everybody. Thank you for your interest in Ferronordic, and welcome to our presentation of the first quarter of 2026. Moving to slide two, summarizing the quarter. We saw revenue amounting…

Good morning, everyone, and welcome to the financial report for our Q4. I, along with Peter Schön, who will come in later in this presentation, will start by giving some highlights from our fourth qua…

Welcome to the Oncopeptides webcast for the first quarter of 2026. Please note the disclaimer regarding forward-looking statements. Today's presentation is led by myself, Sofia Heigis, and our CFO Hen…

Good morning. Good evening everyone. Welcome to Catena Media's Q1 interim report. I am Manuel Stan and today I am joined by our Chief Financial Officer, Mike Gerrow. Today we will be discussing our Q1…

Tack så mycket! Mitt namn är Håkan Dahlström och jag är verkställande direktör för Eltel sedan snart fyra år tillbaka. Och som Joakim och jag konstaterade här för en liten stund sedan, så är det nio å…

Go ahead. Thank you so much. Good day, everyone, and welcome to our first earnings call in 2026. Please note first our forward-looking statements. Here is the agenda for today. I'll start with the…

Welcome to the QleanAir investor presentation for Q1 2026. My name is Sebastian Lindström. I'm the CEO of QleanAir. And joining me in today's call is Fredrik Sandelin, CFO at QleanAir. Fredrik and I…

Welcome, everyone, to the webcast for Ascelia Pharma AB Q1 report for 2026. On this call, we will be making forward-looking statements. On today's call, we will start with an overview of Ascelia Pharm…

Good morning and welcome to this Q1 release presentation for WS WeSports Group. We summarized Q1 2026 as another record-breaking quarter, where we took considerable steps towards our financial targets…

Välkomna till SenzaGen AB Q1 rapport 2026. Första delen av mötet så är vi bara i lyssnarläge, och under frågestunden kan ni trycka Fyrkant fem för att ställa frågor. Förlåt. Och jag lämnar nu över ord…